Previous 10 | Next 10 |
CHARLOTTESVILLE, Va., May 04, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas w...
Gainers: AlloVir (ALVR) +41%. Biophytis (BPTS) +22%. Clarus Therapeutics (CRXT) +22%. Healthcare Services (HCSG) +20%. BioSig Technologies (BSGM) +6%. Losers: Arcturus Therapeutics (ARCT) -22%. Diffusion Pharmaceuticals (DFFN) -13%. Seer (SEER) -7%. HTG Molecular...
Gainers: Checkmate Pharmaceuticals CMPI +333%. Petros Pharmaceuticals (PTPI) +55%. Axsome Therapeutics AXSM +23%. Avinger (AVGR) +11%. Processa Pharmaceuticals (PCSA) +10%. Losers: Lyra Therapeutics (LYRA) -16%. Diffusion Pharmaceuticals (DFFN) -15...
Diffusion Pharmaceuticals (NASDAQ:DFFN) is trading sharply lower in the morning hours on Monday after the development stage biotech announced a 1-for-50 reverse stock split of its common stock. The reverse stock split is expected to take effect at 5:59 p.m. EST on Monday, Diffusion (DFFN) sai...
CHARLOTTESVILLE, Va., April 18, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas...
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) traded at a new 52-week high today of $15.50. Approximately 257.2 million shares have changed hands today, as compared to an average 30-day volume of 1.5 million shares. Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. ...
Topline data expected within two months Blinded, interim data to be presented at the Undersea & Hyperbaric Medical Society’s Annual Scientific Meeting in May 2022 CHARLOTTESVILLE, Va., April 11, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DF...
• Special Meeting of Stockholders Rescheduled to Monday, April 18, 2022 at 9:00 a.m. E.T. • No Change to Meeting Location, Record Date, or Proposals to Be Voted Upon CHARLOTTESVILLE, Va., April 08, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (N...
3 Penny Stocks That Climbed During Trading Today When it comes to penny stocks, there are a lot of different opinions out there. Some people believe that penny stocks are always a good investment, while others think that they’re only worth considering if the market is doing well....
Diffusion Pharmaceuticals press release (NASDAQ:DFFN): FY GAAP EPS of -$0.25. As of December 31, 2021, the Company reported a total of $37.3M in cash and cash equivalents. For further details see: Diffusion Pharmaceuticals GAAP EPS of -$0.25
News, Short Squeeze, Breakout and More Instantly...
Diffusion Pharmaceuticals Inc. Company Name:
DFFN Stock Symbol:
NASDAQ Market:
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) is one of today's top gainers. The company's shares are currently up 15.2% on the day to $4.6. Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product...
Approximately 71% of Stockholders Voted in Favor of the Transaction Diffusion Announces 1-for-1.5 Reverse Stock Split Merger on Track to Close on August 16, 2023 CHARLOTTESVILLE, Va., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) today announced...
NEW YORK, NY / ACCESSWIRE / April 14, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Univar Solutions Inc. (NYSE:UNVR)'s ...